LATEST ALERTS
US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies
Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the issue
Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances
UK member of parliament Steve Brine, a supporter of medical cannabis, has resigned as under-secretary of state for public health over Brexit-related issues
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.
The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.
The UK’s National Institute for Health and Care Excellence (NICE) promises trials of medical cannabis after a senior consultant told a parliamentary committee of his worries about it being widely prescribed
Under current EU rules, cannabinoid-containing hemp extracts could require pre-market authorisation as they are now considered to be novel foods. CBD-Intel explains how the rules work
Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues
Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis
Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains
Lobbyists have highlighted flaws in European authorities’ current classification of cannabinoids as novel foods which could signal change
Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
The US Food and Drug Administration is moving slowly in drawing regulatory boundaries for CBD businesses. Members of Congress have called for clarity, but the FDA says it has no plans to give cannabis derivatives the green light
The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients
The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb
Growing acceptance and use of CBD in Switzerland, as demonstrated in a recent report, could eventually lead to legalisation of cannabis in the country, according to a range of experts
Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers
The United Nations Committee on Narcotic Drugs (UNCND) has delayed voting on cannabis and CBD recommendations in a move that has upset a number of delegates
Whether the left or the right ends up in power – and that is difficult to predict – some form of debate around cannabis could be on the cards following forthcoming general elections in Spain
Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert
Singaporean authorities do not believe there is sufficient evidence supporting the efficacy of “raw” cannabis, considering the plant and its derivatives to be a dangerous drug with few medical benefits
The European Parliament has passed a resolution supporting medical cannabis – though only in cases where a product has gone through clinical trials and a regulatory approval process
The UK’s Food Standards Agency has said there will be no change in UK regulations concerning CBD as a novel food ingredient should the UK leave the EU on 29th March
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
Interest in the Greek CBD market continues to grow despite an uncertain regulatory situation, with a number of apparent cases of police taking action against people acting entirely legally
This report covers the regulatory status of CBD-related products in Sweden
While the EU has allowed varieties of industrial hemp to be grown in Sweden in accordance with EU rules, cannabidiol extracts are currently widely subject to medicines legislation as interpreted by Sweden’s Medical Products Agency.
Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime
Despite the 2018 Farm Act, CBD companies hoping for a national market in the US are still hampered by federal regulations, with products prevented from being sold across state lines
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities
Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised
In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes, and the addition of CBD to cosmetic products, is prohibited
A proposal before the Italian government to legalise personal cultivation and possession of cannabis would also allow cannabis flowers with THC concentrations of up to 1% in foods and as a herbal product
No food item should contain any cannabinoid, including CBD, in the EU without prior novel food ingredient authorisation following a change by European authorities – though this is open to interpretation
Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis
An unconfirmed seizure of products from a shop in Arizona could be the first instance of enforcement on CBD by Food and Drug Administration (FDA) officials since the passage of the US 2018 Farm Bill
Mexico may well become the third country in the world to fully legalise all cannabis products, including marijuana. In the meantime, CBD and hemp-containing products are allowed as long as they contain less than 1% THC
The Canadian government has released proposed regulations for additional products containing cannabis-derived ingredients, including food items, beverages, extracts and topicals
The US Congress is expected to address the legal situation of CBD and cannabis during the upcoming congressional session, according to a number of experts interviewed by CBD-Intel
Pro-cannabis measures are expected to receive at least 18 more votes of support in the new US Congress, according to exclusive research by CBD-Intel, with more than 60 new Representatives supporting legalisation
While CBD has been one of THE stories of 2018, the novelty phase is now over, and 2019 will be the year the longer-term future of CBD products becomes clearer. CBD-Intel looks at prospects for the months ahead
Removing hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned
The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD industry
In our latest regulatory snapshot, we look at Austria where in general the extraction and manufacture of CBD is allowed and hemp can be grown as long as the variety is on some of the key approved lists
Securing cannabis supplies for research purposes is the focus of an information request from the US federal government. They are asking businesses about the ability to analyse, produce, and even distribute cannabis products for research. The National Institute on Drug Abuse (NIDA) is probing for businesses that have the “in-house capability to act as a centralized source for acquisition and/or production, analysis, and distribution of cannabis and related materials for research purposes,” according to a federal notice.
The British government last week presented the 585-page draft withdrawal agreement which lays out how it intends the UK to leave the European Union. Here CBD-Intel explains just how it may affect the CBD industry
In our latest look at Poland, we find that THC is a regulated substance, thus all the products on the market which have not obtained a medical authorisation must be THC-free
In our overview of the regulatory landscape in the United Kingdom we find that while the UK is one of Europe’s largest CBD markets, growing and extracting CBD is restricted and there is a zero-tolerance policy for THC content in CBD products
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
